Mehran Yazdanian
Articles
Early Development GMPs for Small-Molecule Specifications: An Industry Perspective (Part V)
Dennis O'Connor;James S. McElvain;Mark D. Trone;Michael Coutant;Michael Szulc;Mehran Yazdanian;Shuhong Zhang;Scott A. Miller;Peter Yehl;Kirby Wong-Moon;Zhihong Ge;Frank Swanek
October 2nd 2012IQ Consortium representatives explore and define common industry approaches and practices for applying GMPs in early development.
Latest Updated Articles
Published: October 11th 2024 | Updated: October 18th 2024
Buy, Sell, Hold: Cell and Gene Therapy - Part 1
Published: September 10th 2024 | Updated: September 18th 2024
CPHI Milan Announces 2024 CPHI Pharma Award Finalists
Published: February 23rd 2024 | Updated: December 22nd 2024
Europa Perspectives: Helping to Navigate the Regulatory System
Published: December 13th 2024 | Updated: December 22nd 2024
FDA Creates CDER Center for Real-World Evidence Innovation
Published: December 5th 2024 | Updated: December 22nd 2024
Leveraging Advancements in Bioanalytical Testing
Published: December 7th 2024 | Updated: December 22nd 2024
Exploring Opportunities for LNP Delivery in mRNA
